Amgen Inc. (NASDAQ:AMGN) Upgrades/Downgrades review


Amgen Inc. (NASDAQ:AMGN) has a 1 Year Target Estimate of $182.21. The stock traded with the volume of 2.94 Million in the last trading session. Amgen Inc. opened at $145.36 and closed by showing an increase of 0.64%. The Bid price in the last session was $145.50 x 100 and the Ask price was $147.40 x 100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Amgen Inc. has the Market Capitalization of 108.61 Billion. The Stock has its 52-week High of $176.85 and 52-Week Low of $133.64 and it touched its 52-week high on Sep 23, 2016 and 52-Week Low on Nov 4, 2016.

Amgen Inc. reported its last Earnings on Oct 27 where the company reported Actual EPS of $3.02/Share whereas, the Analyst Estimated EPS was $2.79/share. The difference between Actual EPS and Estimated EPS was $0.23/share. This represented an Earnings Surprise of 8.2%. The company will report its next earnings on Jan 26 – Jan 30 (Est.).

Some analyst provided their insight on Growth Estimates; Amgen Inc. has the Current Quarter Earnings Growth rate of 7.3%. The Next Quarter growth is expected to be 1.7%. In the past 5 years, the stock has earnings growth rate of 17.15% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 7.52% per annum.

19 number of analysts also provided their insight on Amgen Inc., where the Average Price Target for the stock is $182.21. They also projected Low Price Target as $157 while High Price Target is set at $209.

A number of analysts rated the stock as well: 2 analysts believe that the stock is a STRONG BUY while 11 reported it as Buy.11 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Amgen Inc. annual Divided is 4 while it’s Dividend Yield is 2.74%. The stock has its Price to Earnings (P/E) ratio of 14.58 and Forward Price to Earnings ratio of 11.65. The company has its Price to Sales (P/S) ratio of 4.81 where Price to Book (P/B) ratio of 3.54, Price to Cash Per share (P/C) of 2.86 and Price to Free Cash Flow (P/FCF) has a value of 385.15.

The company has its Return on Assets (ROA) of 10.1 Percent. Return on Equity (ROE) stands at 25.8% and Return on Investment (ROI) displays a value of 12.5%.

The stock is currently trading at Distance from 20-Day simple moving Average of 1.91% whereas, Distance from 50-Day Simple moving average is -6.35 Percent and Distance from 200-Day Simple Moving Average of -6.46 percent.

A look at performance overview of Amgen Inc. depicts that Performance (Week) is 0.31 percent while Performance Month is 1.24%. Quarterly performance shows a value of -13.92% and Half Year Performance value stands at -6.46%. Yearly performance of the stock has the value of -6.98 percent. Amgen Inc. has its YTD performance of -7.69 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 31 Oct 2016 where Director Kullman (Ellen Jamison) did a transaction type “Buy” in which 355 shares were traded at a price of $0. Another insider trade includes Officer Patton Cynthia M who also initiated a transaction in which 1043 shares were traded on 25 Oct 2016 as “Sell”. On 24 Oct 2016 Officer Mcnamee Brian M traded 2109 shares as “Sell” at $158.76. Director de Carbonnel (François) Buy 5000 shares on 8 Sep 2016 at the price of $71.64.

Upgrades/Downgrades Report:

The latest Upgrades/Downgrades was done by Research firm Mizuho on 8-Nov-16 who Initiated the stock  to Buy. Other firms have also Upgraded/Downgraded the stock. On 26-Aug-16, Gabelli & Co took an action “Initiated”  to Hold. On 29-Jun-16, the stock was Initiated to Mkt Perform by Bernstein.